Further evidence that 6-MP taken by the father with IBD provides risk of congenital anomaly to the pregnancy.
Korelitz
B I
BI
Rajapakse
R O
RO
D000328:Adult; D000649:Amniocentesis; D000013:Congenital Abnormalities / Q000209:etiology* / Q000517:prevention & control; D005220:Fathers; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007231:Infant, Newborn; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects* / Q000627:therapeutic use; D018812:Paternal Exposure / Q000009:adverse effects*; D011247:Pregnancy; D018570:Risk Assessment
D007166:Immunosuppressive Agents; D015122:Mercaptopurine